Prognostic Impact of Node-Spreading Pattern in Surgically Treated Small-Cell Lung Cancer: A Multicentric Analysis
- 151 Downloads
Abstract
Objective
Although surgery in selected small-cell lung cancer (SCLC) patients has been proposed as a part of multimodality therapy, so far, the prognostic impact of node-spreading pattern has not been fully elucidated. To investigate this issue, a retrospective analysis was performed.
Methods
From 01/1996 to 12/2012, clinico-pathological, surgical, and oncological features were retrospectively reviewed in a multicentric cohort of 154 surgically treated SCLC patients. A multivariate Cox proportional hazard model was developed using stepwise regression, in order to identify independent outcome predictors. Overall (OS), cancer-specific (CSS), and Relapse-free survival (RFS) were calculated by Kaplan-Meier method.
Results
Overall, median OS, CSS, and RFS were 29 (95 % CI 18–39), 48 (95 % CI 19–78), and 22 (95 % CI 17–27) months, respectively. Lymphadenectomy was performed in 140 (90.9 %) patients (median number of harvested nodes: 11.5). Sixty-seven (47.9 %) pN0-cases experienced the best long-term survival (CSS: 71, RFS: 62 months; p < 0.0001). Among node-positive patients, no prognostic differences were found between pN1 and pN2 involvement (CSS: 22 vs. 15, and RFS: 14 vs. 10 months, respectively; p = 0.99). By splitting node-positive SCLC according to concurrent N1-invasion, N0N2-patients showed a worse CSS compared to those cases with combined N1N2-involvement (N0N2: 8 months vs. N1N2: 22 months; p = 0.04). On the other hand, the number of metastatic stations (p = 0.80) and the specific node-level (p = 0.85) did not affect CSS. At multivariate analysis, pN+ (HR: 3.05, 95 % CI 1.21–7.67, p = 0.02) and ratio between metastatic and resected lymph-nodes (RL, HR: 1.02, 95 % CI 1.00–1.04, p = 0.03) were independent predictors of CSS. Moreover, node-positive patients (HR: 3.60, 95 % CI 1.95–6.63, p < 0.0001) with tumor size ≥5 cm (HR: 1.85, 95 % CI 0.88–3.88, p = 0.10) experienced a worse RFS.
Conclusions
In selected surgically treated SCLC, the long-term survival may be stratified according to the node-spreading pattern.
Keywords
Small-cell lung cancer Surgery Lymphadenectomy Node-spreading pattern Ratio Multimodality therapyNotes
Acknowledgments
We would like to thank Ms. Tania Merlino for her assistance in revising the manuscript.
Compliance with ethical standards
Conflict of interest
None.
References
- 1.Riaz S, Luchtenborg M, Coupland VB et al (2012) Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer 75:280–284CrossRefPubMedGoogle Scholar
- 2.Lassen U, Osterlind K, Hansen M et al (1995) Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years–an analysis of 1,714 consecutive patients. J Clin Oncol. 13(5):1215–1220PubMedGoogle Scholar
- 3.Sawabata N, Miyaoka E, Asamura H et al (2011) Japanese Lung Cancer Registry Study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol 6:1229–1235CrossRefPubMedGoogle Scholar
- 4.Govindan R, Page N, Morgensztern D et al (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 24(28):4539–4544CrossRefPubMedGoogle Scholar
- 5.Combs SE, Hancock JG, Boffa DJ et al (2015) Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base. J Thorac Oncol. 10(2):316–323CrossRefPubMedGoogle Scholar
- 6.Hara N, Ohta M, Ichinose Y et al (1991) Influence of surgical resection before and after chemotherapy on survival in small cell lung cancer. J Surg Oncol 47:53–61CrossRefPubMedGoogle Scholar
- 7.Shepherd FA, Evans WK, Feld R et al (1988) Adjuvant chemotherapy following surgical resection for small-cell carcinoma of the lung. J Clin Oncol 6:832–838PubMedGoogle Scholar
- 8.Badzio A, Kurowski K, Karnicka-Mlodkowska H et al (2004) A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer. Eur J Cardiothorac Surg 26(1):183–188CrossRefPubMedGoogle Scholar
- 9.Edge SB, Byrd DR, Compton CC, et al (eds) (2010) AJCC-Cancer Staging Manual, 7th edn. Springer, Chicago, pp 299–323Google Scholar
- 10.Travis WD, Brambilla E, Muller-Hermelink HK (2004) World Health Organization classification of tumours: pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, LyonGoogle Scholar
- 11.Fox W, Scadding JG (1973) Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus: ten-year follow-up. Lancet 2:63–65CrossRefPubMedGoogle Scholar
- 12.Lad T, Piantadosi S, Thomas P et al (1994) A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy. Chest 106:320–323CrossRefGoogle Scholar
- 13.Jett JR, Schild SE, Kesler KA, et al. (2013) Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd edn. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143 (5 Suppl):e400S-19SGoogle Scholar
- 14.Inoue M, Miyoshi S, Yasumitsu T et al (2000) Surgical results for small cell lung cancer based on the new TNM staging system. Ann Thorac Surg 70:1615–1619CrossRefPubMedGoogle Scholar
- 15.Miyamoto M, Morikawa T, Kaga K et al (2006) Subcarinal node is the significant node that affects survival in resected small cell lung cancer. Surg Today 36(8):671–675CrossRefPubMedGoogle Scholar
- 16.Bria E, Milella M, Sperduti I et al (2009) A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. Lung Cancer. 66(3):365–371CrossRefPubMedGoogle Scholar
- 17.Legras A, Mordant P, Arame A et al (2014) Long-term survival of patients with pN2 lung cancer according to the pattern of lymphatic spread. Ann Thorac Surg. 97(4):1156–1162CrossRefPubMedGoogle Scholar
- 18.Naruke T, Suemasu K, Ishikawa S (1978) Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 76(6):832–839PubMedGoogle Scholar
- 19.Kobayashi S, Okada S, Hasumi T et al (2000) The significance of surgery for bulky N2 small-cell lung cancer: a clinical and in vitro analysis of long-term survivors. Surg Today 30(11):978–986CrossRefPubMedGoogle Scholar
- 20.Inoue M, Nakagawa K, Fujiwara K et al (2000) Results of preoperative mediastinoscopy for small cell lung cancer. Ann Thorac Surg 70:1620–1623CrossRefPubMedGoogle Scholar
- 21.Vallieres E, Shepherd FA, Crowly J et al (2009) The IASLC proposals regarding the pathologic staging of small cell lung cancer in forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol. 4:1049–1059CrossRefPubMedGoogle Scholar
- 22.Wada H, Nakajima T, Yasufuku K et al (2010) Lymph node staging by endobronchial ultrasound- guided transbronchial needle aspiration in patients with small cell lung cancer. Ann Thorac Surg 90:229–234CrossRefPubMedGoogle Scholar